Kilroy Realty Corp

Kilroy Realty Corp maintains a capital structure characterized by total assets of $10.77 billion and total equity of $5.27 billion as of Q1 2026. The valuation snapshot indicates a price-to-book ratio of 0.75 and a price-to-tangible-book ratio of 0.72, suggesting the market values the company below its book value. The debt-to-equity ratio is reported as 0.0 in the valuation snapshot, although the cash flow statement reveals interest expenses of $38.5 million and principal payments on secured debt, indicating the presence of leverage not fully captured in the simplified ratio or offset by specific accounting treatments. Liquidity is assessed as low, with cash and equivalents standing at $192.9 million against operating cash flows of $150.7 million for the quarter.

Profitability metrics show a net loss attributable to common stockholders of $19.3 million for Q1 2026, compared to a net income of $39.0 million in the same period of the prior year. This decline is driven by a $61.8 million impairment of real estate assets, partially offset by $23.5 million in gains on sales of depreciable operating properties. Operating cash flow remains positive at $150.7 million, demonstrating the underlying cash-generating ability of the portfolio despite the non-cash impairment charges. The company’s return on equity and return on assets are not explicitly provided in the valuation snapshot, but the net loss impacts these returns negatively for the period.

Revenue concentration is evident in the filing observations, which detail rental income of $265.3 million and other property income of $4.7 million, totaling $270.1 million for Q1 2026. The company’s tenants are primarily in the technology, life science and healthcare, finance, insurance and real estate, and media, professional business and other service firm industries. Geographic exposure is not explicitly detailed in the provided segments, but the nature of the office portfolio suggests a focus on major metropolitan markets where these industries are concentrated.

Growth trajectory analysis shows total revenues of $270.1 million in Q1 2026, slightly down from $270.8 million in Q1 2025. The company engaged in significant investing activities, including $102.6 million in expenditures for development and redevelopment properties and $29.9 million for operating properties. These investments were partially funded by $141.4 million in net proceeds from dispositions of real estate assets, indicating a strategy of recycling capital from older assets into new development or redevelopment projects.

Risk factors include medium dilution risk, as indicated by the risk assessment, and potential liquidity constraints. The company faces risks related to tenant defaults, particularly in the technology and life science sectors, which could impact rental income and property values. Additionally, the company’s ability to obtain financing on acceptable terms may be limited by market volatility, affecting its capacity to pursue acquisition and development opportunities. The impairment of real estate assets highlights the sensitivity of property values to market conditions.

Recent events include the filing of consolidated statements of operations and cash flows for Q1 2026, which disclose the net loss and cash flow dynamics. Analyst estimates suggest a mean price target of $37.00, with a median of $38.00, indicating moderate upside potential from the current market price of $33.37. The mean recommendation of 2.81 reflects a mixed sentiment among analysts, with 2 strong buys, 1 buy, and 11 holds.

Revenue $4.7M.

• ▍Revenue $4.7M

Revenue $14.3M.

• ▍Revenue $14.3M

Revenue $9.4M.

• ▍Revenue $9.4M

Revenue $19.1M.

• ▍Revenue $19.1M

Revenue $17.5M.

• ▍Revenue $17.5M

Revenue $17.5M.

• ▍Revenue $17.5M

Revenue $12.0M.

• ▍Revenue $12.0M

Revenue $12.0M.

• ▍Revenue $12.0M